Newcastle paper's campaign success overturned

Six months ago the Newcastle Evening Chronicle was celebrating a successful conclusion to its campaign on behalf of cancer patients. It thought it had won patients dying from mesothelioma access to the drug Alimita which would extend their lives, albeit for a short time. But the National Institute for Health and Clinical Evidence has ruled against providing the necessary funding, and the paper has called on readers to renew the campaign. (Via icNewcastle - Evening Chronicle - Local News)